DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Relpax (Eletriptan) - Reports of Side Effects & Adverse Reactions

 


Nutrilib.com
A comprihensive source of nutritional information

This is an index of adverse event reports related to Relpax (Eletriptan). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (61)
     Migraine (11)Intentional Drug Misuse (7)Drug Dependence (7)more >>

Cases resulting in a serious event (61)
     Migraine (11)Intentional Drug Misuse (7)Drug Dependence (7)more >>

Cases resulting in death (1)
     Angiopathy (1)Cardiac Arrest (1)

Cases resulting in life threatening events (2)
     Confusional State (1)Respiratory Rate Increased (1)Food Intolerance (1)more >>

Cases resulting in hospitalization (17)
     Migraine (2)Angioedema (2)Drug Abuser (2)more >>

Cases resulting in disability (3)
     Confusional State (2)Dysmorphism (2)Hypotension (2)more >>

Cases resulting in other serious reactions (47)
     Migraine (11)Intentional Drug Misuse (7)Drug Dependence (7)more >>

Below is a sample of adverse event reports reports related to Relpax (Eletriptan). For a complete list and/or a specific selection of reports, please use the links in the index above.

Adverse event in 27 year old female receiving Relpax (Eletriptan)

Reported by a physician from Switzerland on 2007-10-29

Patient: 27 year old female

Adverse reactions / side effects: Angioedema, Type I Hypersensitivity

Adverse event resulted in: hospitalization

Suspect drug(s):
Relpax
    Dosage: text:if needed
    Administration route: Oral
    Indication: Migraine
    Start date: 2005-01-01
    End date: 2007-10-02

Dafalgan
    Administration route: Oral
    Indication: Migraine



Adverse event in 32 year old female receiving Relpax (Eletriptan)

Reported by a individual with unspecified qualification from United States on 2007-10-18

Patient: 32 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Blighted Ovum, Abortion Spontaneous, Pregnancy

Suspect drug(s):
Dynacin
    Indication: Sweat Gland Infection
    End date: 2007-03-01

Rebif
    Dosage: 44 mcg/3 times wkly/sc
    Indication: Multiple Sclerosis
    Start date: 2006-03-14
    End date: 2007-03-01

Seroquel
    Indication: Insomnia
    End date: 2007-03-01

Relpax
    Dosage: prn
    Indication: Migraine
    End date: 2007-03-01

Celexa
    Indication: Depression
    End date: 2007-03-01

Provigil
    Indication: Fatigue
    End date: 2007-03-01

Vesicare
    Indication: Bladder Disorder
    End date: 2007-03-01

Baclofen
    Indication: Muscle Spasms
    End date: 2007-03-01



Adverse event in 32 year old female receiving Relpax (Eletriptan)

Reported by a consumer/non-health professional from United States on 2007-10-15

Patient: 32 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Abortion Spontaneous

Suspect drug(s):
Vesicare
    Indication: Urinary Tract Disorder
    End date: 2007-03-01

Rebif
    Dosage: 44 other, subcutaneous
    Indication: Multiple Sclerosis
    Start date: 2006-03-14
    End date: 2007-03-01

Seroquel
    Indication: Insomnia
    End date: 2007-03-01

Relpax
    Indication: Migraine
    End date: 2007-03-01

Minocycline(minocycline Hydrochloride
    Indication: Sweat Gland Infection
    End date: 2007-03-01

Provigil
    Indication: Fatigue
    End date: 2007-03-01

Baclofen
    Indication: Muscle Spasms
    End date: 2007-03-01

Celexa
    Indication: Depression
    End date: 2007-03-01



Adverse event in female receiving Relpax (Eletriptan)

Reported by a pharmacist from United States on 2007-10-09

Patient: female

Adverse reactions / side effects: Tooth Fracture

Suspect drug(s):
Relpax (Eletriptan)

Other drugs received by patient: ALL Other Therapeutic Products



Adverse event in 45 year old male receiving Relpax (Eletriptan)

Reported by a pharmacist from Japan on 2007-10-08

Patient: 45 year old male

Adverse reactions / side effects: Myalgia, Musculoskeletal Stiffness

Suspect drug(s):
Relpax (Eletriptan)

Other drugs received by patient: ALL Other Therapeutic Products



Adverse event in female receiving Relpax (Eletriptan)

Reported by a consumer/non-health professional from United States on 2007-10-02

Patient: female

Adverse reactions / side effects: Abortion Spontaneous

Suspect drug(s):
Relpax
    Indication: Migraine

Rebif
    Indication: Multiple Sclerosis
    Start date: 2006-03-14
    End date: 2007-03-01

Seroquel
    Indication: Insomnia

Provigil
    Indication: Fatigue

Vesicare
    Indication: Bladder Disorder

Baclofen
    Indication: Muscle Spasms

Minocycline HCL
    Indication: Sweat Gland Infection

Celexa
    Indication: Depression



Adverse event in 45 year old male receiving Relpax (Eletriptan)

Reported by a pharmacist from Japan on 2007-10-01

Patient: 45 year old male

Adverse reactions / side effects: Myalgia, Musculoskeletal Stiffness

Suspect drug(s):
Relpax (Eletriptan)

Other drugs received by patient: ALL Other Therapeutic Products



Adverse event in female receiving Relpax (Eletriptan)

Reported by a consumer/non-health professional from United States on 2007-07-23

Patient: female, weighing 69.1 kg (152.0 pounds)

Adverse reactions / side effects: Speech Disorder, Vomiting, Drug Ineffective, Mutism, Photophobia, Headache, Gait Disturbance

Suspect drug(s):
Relpax (Eletriptan)

Other drugs received by patient: Excedrin (Migraine)



Adverse event in female receiving Relpax (Eletriptan)

Reported by a consumer/non-health professional from United States on 2007-07-18

Patient: female, weighing 113.4 kg (249.5 pounds)

Adverse reactions / side effects: LIP Swelling, Skin Disorder, Eye Swelling, Eye Pruritus

Suspect drug(s):
Relpax (Eletriptan)

Other drugs received by patient: Atenolol; Topamax; Diamox



Adverse event in female receiving Relpax (Eletriptan)

Reported by a consumer/non-health professional from United States on 2007-07-12

Patient: female

Adverse reactions / side effects: Arteriospasm Coronary, Cardiomyopathy

Adverse event resulted in: hospitalization

Suspect drug(s):
Amerge
    Administration route: Oral
    Indication: Migraine

Imitrex
    Administration route: Oral
    Indication: Migraine

Axert
    Indication: Migraine

Frova

Relpax



Adverse event in female receiving Relpax (Eletriptan)

Reported by a physician from United States on 2007-07-12

Patient: female

Adverse reactions / side effects: Intentional Drug Misuse, Drug Dependence

Suspect drug(s):
Relpax (Eletriptan)



Adverse event in 82 year old male receiving Relpax (Eletriptan)

Reported by a physician from United States on 2007-07-10

Patient: 82 year old male

Adverse reactions / side effects: Dementia Alzheimer's Type, Amnesia

Suspect drug(s):
Relpax (Eletriptan)



Adverse event in 44 year old female receiving Relpax (Eletriptan)

Reported by a consumer/non-health professional from United States on 2007-06-29

Patient: 44 year old female, weighing 94.8 kg (208.6 pounds)

Adverse reactions / side effects: Flushing, Migraine, Chest Discomfort, Nausea, DRY Mouth, Dizziness

Suspect drug(s):
Geodon
    Indication: Bipolar I Disorder

Relpax
    Indication: Migraine

Relpax
    Indication: Cluster Headache

Trazodone HCL
    Indication: Bipolar I Disorder

Depakote
    Indication: Bipolar I Disorder

Other drugs received by patient: ALL Other Therapeutic Products



Adverse event in female receiving Relpax (Eletriptan)

Reported by a consumer/non-health professional from United States on 2007-06-28

Patient: female

Adverse reactions / side effects: Arteriospasm Coronary, Cardiomyopathy

Adverse event resulted in: hospitalization

Suspect drug(s):
Amerge
    Administration route: Oral
    Indication: Migraine

Imitrex
    Administration route: Oral
    Indication: Migraine

Frova

Relpax



Adverse event in 50 year old female receiving Relpax (Eletriptan)

Reported by a consumer/non-health professional from United States on 2007-06-27

Patient: 50 year old female, weighing 65.8 kg (144.7 pounds)

Adverse reactions / side effects: Agitation, Confusional State, Food Intolerance, Hypoventilation, Pyrexia, Serotonin Syndrome, Hyperhidrosis, Abdominal Tenderness, Malaise, Feeling Hot, Coordination Abnormal, Respiratory Rate Increased, Chest Discomfort, Nausea, Restlessness, Localised Oedema, Tremor, Panic Attack, Diarrhoea, Hypertension

Adverse event resulted in: life threatening event

Suspect drug(s):
Effexor XR
    Dosage: 150 mg daily po
    Administration route: Oral
    Indication: Depression
    Start date: 2005-08-01
    End date: 2007-06-25

Relpax
    Dosage: 40 mg twice daily prn po
    Administration route: Oral
    Indication: Migraine
    Start date: 2003-01-01
    End date: 2007-06-26



Adverse event in female receiving Relpax (Eletriptan)

Reported by a lawyer from France on 2007-06-27

Patient: female, weighing 50.0 kg (110.0 pounds)

Adverse reactions / side effects: Facial Palsy, Dysmorphism, Tinnitus, Personality Disorder, Cerebral Ischaemia, Balance Disorder, Drug Administration Error, Unevaluable Event, Mood Swings, Haematoma, Hypotension, Hypoaesthesia, Aggression, Loss of Proprioception, Disturbance in Attention, Confusional State, Accommodation Disorder, Impaired Work Ability, Aphasia, LIP Oedema, Disorientation, Somnolence, Fall, Extensor Plantar Response, Myalgia, Overdose, Fatigue, Vasoconstriction, Clumsiness, Dysgraphia, Transient Ischaemic Attack, Migraine, Tooth Fracture, Motor Dysfunction, Multiple-Drug Resistance, Joint Dislocation, Amnesia, Cerebrovascular Accident, Dysarthria, Anxiety, Social Problem, Ageusia, Diarrhoea, Visual Disturbance, Gait Disturbance, Asthenia

Adverse event resulted in: disablity

Suspect drug(s):
Relpax
    Dosage: daily dose:80mg-freq:prn
    Indication: Migraine Without Aura
    Start date: 2003-01-01
    End date: 2003-10-15

Relpax
    Indication: Migraine

Hept-A-MYL
    Dosage: daily dose:760gram-freq:qid
    Administration route: Oral
    Indication: Hypotension
    Start date: 2003-10-08
    End date: 2003-10-26

Ginko Biloba
    Dosage: text:unknown-freq:unknown
    Administration route: Oral
    Start date: 2003-10-11
    End date: 2003-11-02



Adverse event in female receiving Relpax (Eletriptan)

Reported by a physician from United States on 2007-06-27

Patient: female, weighing 54.4 kg (119.7 pounds)

Adverse reactions / side effects: Speech Disorder, Dyspnoea, Eye Swelling, Throat Tightness

Suspect drug(s):
Relpax (Eletriptan)



Adverse event in female receiving Relpax (Eletriptan)

Reported by a physician from France on 2007-06-22

Patient: female

Adverse reactions / side effects: Drug Abuser

Suspect drug(s):
Relpax (Eletriptan)



Adverse event in 40 year old female receiving Relpax (Eletriptan)

Reported by a physician from Morocco on 2007-06-22

Patient: 40 year old female, weighing 70.0 kg (154.0 pounds)

Adverse reactions / side effects: Syncope, Orthostatic Hypotension

Suspect drug(s):
Relpax (Eletriptan)



Adverse event in female receiving Relpax (Eletriptan)

Reported by a physician from Japan on 2007-06-20

Patient: female

Adverse reactions / side effects: Haemorrhage Subcutaneous

Suspect drug(s):
Relpax (Eletriptan)



Adverse event in female receiving Relpax (Eletriptan)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-19

Patient: female

Adverse reactions / side effects: Overdose, Headache

Adverse event resulted in: hospitalization

Suspect drug(s):
Relpax (Eletriptan)



Adverse event in receiving Relpax (Eletriptan)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-18

Patient:

Adverse reactions / side effects: Intentional Drug Misuse, Drug Dependence

Suspect drug(s):
Relpax (Eletriptan)



Adverse event in female receiving Relpax (Eletriptan)

Reported by a physician from Austria on 2007-06-11

Patient: female, weighing 70.0 kg (154.0 pounds)

Adverse reactions / side effects: Migraine, Micturition Disorder, Intentional Drug Misuse, Drug Dependence

Adverse event resulted in: hospitalization

Suspect drug(s):
Relpax (Eletriptan)

Other drugs received by patient: Paspertin; Pantoprazole Sodium



Adverse event in female receiving Relpax (Eletriptan)

Reported by a physician from United States on 2007-06-07

Patient: female

Adverse reactions / side effects: Dyspnoea, Eye Swelling, Throat Tightness

Suspect drug(s):
Relpax (Eletriptan)



Adverse event in 25 year old female receiving Relpax (Eletriptan)

Reported by a physician from Japan on 2007-06-01

Patient: 25 year old female

Adverse reactions / side effects: Haemorrhage Subcutaneous

Suspect drug(s):
Relpax (Eletriptan)

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008